In melanoma cells, nicotine increased α9 nicotinic acetylcholine receptor activity and activated AKT and ERK signaling pathways, and at the same time, upregulated PD-L1 expression via transcription factor STAT3 binding to the PD-L1 promoter [10]. Here, CD274 is linked to melanoma.